Virobay
Latest round
- Series B
Last raised
- Jul 2014
Total raised
- $23M
Investors
- 5
About Virobay
Virobay Inc.Founded in 2006 and headquartered in Menlo Park, US, Virobay Inc. specializes in designing protease inhibitors. The company has not undergone significant pivots in its business strategy. Virobay was established through the efforts of industry professionals; however, specific founder details are not available.Virobay, Inc. specializes in the design and development of protease inhibitors, primarily targeting autoimmune diseases, neuropathic pain, liver diseases, and cancer. Their lead compounds, including VBY-036 and VBY-891, are under clinical development with specific applications for the treatment of neuropathic pain and oral psoriasis, respectively. VBY-036 commenced its Phase 1 Trial in 2013, while VBY-891 is being developed in collaboration with LEO Pharma. The company employs a virtual model for drug discovery, leveraging both in-house expertise and external contract research and manufacturing resources to ensure efficient and cost-effective development.Virobay's revenue model is predominantly structured around partnerships and collaborations with pharmaceutical companies, such as the multi-million dollar agreement with LEO Pharma for the development of psoriasis treatments. Revenue is derived from contractual agreements related to research and development services, as well as potential royalties from future sales of developed products. The company is also focused on expanding its market presence in North America and Europe, with potential collaborations targeting additional therapeutic areas slated for exploration by the end of 2025. These initiatives are part of Virobay's strategic vision to enhance its pipeline and establish itself as a key player in the biopharmaceutical sector.
Who invested in Virobay
5 investors across 3 rounds
See all investors in Virobay
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Virobay
Who invested in Virobay?
Virobay has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Virobay raised?
Virobay has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Virobay last raise money?
Virobay's most recent round on record is a Series B, in Jul 2014.
What does Virobay do?
Virobay is a pharmaceuticals company.
Where is Virobay headquartered?
Virobay is headquartered in Menlo Park, US.
Which VCs invest in companies like Virobay?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Virobay's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Virobay? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.